{
    "2020-09-11": [
        [
            {
                "time": "",
                "original_text": "里昂：予泰格医药(3347.HK)“买入”评级目标价136.38港元",
                "features": {
                    "keywords": [
                        "里昂",
                        "泰格医药",
                        "买入",
                        "评级",
                        "目标价",
                        "136.38港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}